https://european-biotechnology.net/wp-content/uploads/2025/03/EB125_Insight_Czeslaw-Siekierski_tg-1030x435-1.jpeg4351030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-17 10:27:522025-03-17 10:27:52Poland breaks opposition to EU NGT deregulation
https://european-biotechnology.net/wp-content/uploads/2025/03/SpliceBio-1030x465-1.jpg4651030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-14 09:32:332025-03-14 09:32:33SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease
https://european-biotechnology.net/wp-content/uploads/2025/03/FSA-1030x719-1.jpeg7191030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-12 11:50:152025-03-12 11:50:15Regulatory sandbox will speed up safety assessment of cell-based food
https://european-biotechnology.net/wp-content/uploads/2025/03/Hummingbird-2.png9441000Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-03-04 09:30:182025-03-04 09:30:18ADC maker Callio Therapeutics secures US$187m in Series A round
